SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-016837
Filing Date
2023-07-03
Accepted
2023-07-03 18:00:08
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15330
  Complete submission text file 0000899243-23-016837.txt   16906
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 767 5TH AVENUE 44TH FLOOR NEW YORK NY 10153
Business Address
Gutfreund John Peter (Reporting) CIK: 0001940797 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 231066138